idarucizumab

An 85-year old patient with severe ongoing bleeding

24 november 2022

Abstract In this case report, we describe an 85-year-old female patient who presented with a rare but important problem of anticoagulant rebound complicating dabigatran use. Despite multiple attempts to correct the bleeding, it continued and the coagulation times remained prolonged. Important risk factors for high dabigatran concentrations and prolonged coagulation…